Michael Acurio, MD
Orthopaedic Surgery of the Spine · Bossier City, LANPI 1982606356
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,388 of the $6,097 with a category attached, or 88.4%. 24 manufacturers reported payments, led by Stryker at 47.4% of the total. Reporting peaked in 2020 at $1,696 and has fallen 66.3% since, to $571 in 2025. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in LA, where the typical reported total is $12,239.
Across 219 payments — averaging $27.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Smith+Nephew$2K
- Amgen$456
- AbbVie$172
- KCI USA, Inc.$122
- Boston Scientific$116
- plus $709 from 18 others
What the payments were for
- Travel & lodging$70912%
- Food & beverage$5,38888%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 82 | $2,888 |
| Smith+Nephew | 50 | $1,635 |
| Amgen | 30 | $456 |
| AbbVie | 8 | $172 |
| KCI USA, Inc. | 9 | $122 |
| Boston Scientific | 4 | $116 |
| Dynasplint Systems Inc. | 6 | $97 |
| Pacira Therapeutics, Inc. | 3 | $66 |
| Sanara Medtech Inc. | 1 | $64 |
| Innovation Technologies Inc | 2 | $63 |
| Axogen | 3 | $61 |
| Sanofi-aventis U.S. LLC | 4 | $57 |
| Johnson & Johnson(2 entities) | 3 | $47 |
| Medacta USA, Inc. | 1 | $45 |
| Fidia Pharma USA Inc. | 3 | $43 |
| Bioventus LLC | 2 | $30 |
| Organogenesis Inc. | 1 | $26 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Convatec Inc. | 1 | $17 |
| Vertex | 1 | $17 |
| Vericel Corporation | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Baudax Bio Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,097 in reported general payments places this provider in the 30th percentile of 29 orthopaedic surgery of the spine providers in Louisiana.
See all orthopaedic surgery of the spine providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 72 | $15,892 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 844 | $9,856 |
| Celecoxib | 297 | $6,151 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 430 | $6,016 |
| Gabapentin | 141 | $4,479 |
| Prednisone | 780 | $3,191 |
| Methylprednisolone | 340 | $2,015 |
| Hydroxyzine Hcl | 208 | $1,602 |
| Tramadol Hcl | 202 | $1,502 |
| Duloxetine Hcl | 97 | $1,044 |
| Risedronate Sodium | 15 | $873 |
| Pregabalin | 82 | $660 |
| Cyclobenzaprine Hcl | 75 | $459 |
| Diclofenac Sodium | 24 | $459 |
| Meloxicam | 105 | $360 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $47 | $15,89272 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 29 orthopaedic surgery of the spine providers in Louisiana.
Other orthopaedic surgery of the spine in Bossier City
- Mathew CyriacNew Orleans$368K
- Joseph ZavatskyMetairie$205K
- Lon BaronneLafayette$190K
- Alexis WaguespackMetairie$63K
- Charles YuNew Orleans$52K
- Stephen HogeShreveport$48K
- William AccoustiNew Orleans$46K
- Amit BhandutiaNew Orleans$39K
- Milan ModyShreveport$33K
- Christopher CenacHouma$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.